View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
October 12, 2021

Coronavirus company news summary – Germany ends free rapid Covid-19 antigen tests – Compass Community Health to provide at-home Covid-19 test for free

By Chloe Kent

Germany has decided to no longer offer rapid Covid-19 antigen tests for free as part of new rules aimed at boosting vaccination numbers. The tests have been funded using taxpayer money since March this year. Now, they will only be available for free to children aged under 12 and people who cannot get vaccinated for medical reasons, The Local reported. Free tests will be offered to people aged 12 to 17 years and pregnant women until the end of this year.

NxGen MDx is set to extend its existing drive-through Covid-19 testing site in Holland, Michigan, US to a new location in Grand Rapids. At the new site, full-time Covid-19 polymerase chain reaction (PCR) tests, 15-minute rapid antigen tests and COVID Plus tests for detecting influenza A/B and SARS-CoV-2 will be offered. Kent County is currently seeing an average of 266 Covid-19 cases in a day.

Compass Community Health in the US, a member of the Ohio Association of Community Health Centers (OACHC), is set to supply more than 400 Abbott BinaxNOW at-home Covid-19 test kits to at-risk area residents for free to reduce disease spread in the region. The kits have an accuracy of 84.6%, and contain the necessary nasal swab, instruction manual and other components to carry out the test in the at-home setting, The Portsmouth Daily Times reported.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network